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Abstract 
Introduction: It has been known for a long time that the efficiency and toxicity of drugs 
change during a 24-hour period. However, the molecular mechanisms involved in these 
regulations have started to emerge only recently. 
Areas covered: This review aims to highlight recent discoveries showing the direct role of 
the molecular circadian clock on xenobiotic metabolism at the transcriptional and post-
transcriptional level in the liver and intestine, but also the different ways of elimination of 
these metabolized drugs via biliary and urine excretion. Most of the related literature focuses 
on transcriptional regulation by the circadian clock of xenobiotic metabolism in the liver, 
however the role of this timing system on metabolized drugs excretion and the importance of 
the kidney on this phenomenon are generally neglected. The goal of this review is to describe 
the molecular mechanisms involved in rhythmic drug metabolism and excretion. 
Expert opinion: Chronopharmacology analyses the metabolism of drugs in mammals 
according to the time of day. The circadian timing system plays a key role in these changes of 
toxicity of drugs by influencing their metabolisms in the liver and intestine in addition to 
their excretion via bile flow and urine. 
Article Highlights 
● It has been known for a long time that drug efficiency and toxicity depend on the time of 
administration, however the mechanisms involved have only started to emerge recently. 
● There is clear evidence that the molecular circadian clock is involved in this process. 
● The molecular clock acts either directly or through the rhythmic expression of clock-
controlled transcription factors that regulate the expression of detoxification enzymes or 
indirect pathways. 
● The molecular clock is not only involved in the drug metabolizing process, but also in the 
elimination of the metabolized compounds through the hepathobiliary system and the kidney. 
● The circadian clock-coordinated drug detoxification has a strong impact in the 
pharmacokinetics of drugs and, with the known chronodynamics mechanisms influencing 
drugs efficiency, constitutes the base of Chronopharmacology. 
1. Introduction 
Circadian clocks are operative in virtually all light-sensitive organisms, including 
cyanobacteria, fungi, plants, protozoans and metazoans. The main function of these timing 
devices is the adaptation of the physiological needs of their possessors to the time of day in 
an anticipatory way. In mammals, circadian pacemakers regulate many systemic processes, 
such as sleep-wake cycles, body temperature, heartbeat, and many physiological outputs 
conducted by peripheral organs, such as liver, kidney and the digestive tract. It was 
established on the basis of surgical ablation and transplantation experiments that the 
suprachiasmatic nuclei (SCN), two bilateral groups of neurons located in the hypothalamus, 
coordinates most daily rhythms in behaviour and physiology [1]. In mammals, photic inputs 
are perceived by the retina and transmitted by means of electrical signals directly to SCN 
neurons via the retino-hypothalamic tract. The SCN clock thus synchronizes overt rhythms in 
physiology and behaviour, probably through both synaptic connections and humoral signals 
(for a review, see [2]). 
Since the discovery of the Clock 19 mutant in 1994, the first mutant mice exhibiting a 
circadian phenotype [3], impressive progress has been made in the elucidation of molecular 
mechanisms generating circadian oscillations in a variety of systems. As several clock genes 
are homologous in flies and mammals, it is likely that these mechanisms have been largely 
conserved during animal evolution (for a review, see [4]). The key negative components of 
this genetic circuit are the genes encoding the repressors CRYPTOCHROMES (Cry1 and 
Cry2) and PERIODS (Per1 and Per2). These genes are activated by the PAS domain basic 
helix-loop-helix transcription factors BMAL1 in collaboration with its heterodimerization 
partners CLOCK or NPAS2, which constitute the key positive components of the circadian 
oscillator [5,6]. PER and CRY proteins form heteropolymeric complexes, and once these 
complexes have reached a critical concentration in the cell nucleus, PER binds to the 
BMAL1-CLOCK/NPAS2 heterodimers and thereby permits the inhibition of these 
transcription factors by CRY [7]. As a consequence Cry and Per mRNAs and proteins 
decrease in concentration, and when CRY–PER complexes are not able to repress BMAL1, a 
new cycle of Per and Cry transcription can start. The same activators and repressors drive the 
circadian expression of the orphan nuclear receptor REV-ERB  which periodically represses 
the Retinoic Orphan Receptors (ROR) activated Bmal1 expression and then contributes to the 
circadian expression of Bmal1 [8,9]. Many additional regulators acting at the post-
translational level contribute to the robustness of the molecular clockwork circuit, including 
Casein kinase 1 (CK1) phosphorylating PER proteins [10-12] and the recently characterized 
ubiquitin ligase complex protein SCF
FBXL3
 [13-15] involved in CRY degradation after its 
phosphorylation by adenosine monophosphate-activated protein kinase (AMPK) [16] (see 
Figure 1). 
These time-keeping oscillators do not only exist in pacemaker cells such as SCN neurons but 
are also found in peripheral, non-neuronal tissues of several animals. In mammals, light 
resets the time of the central pacemaker in the SCN via ocular mechanisms, and the SCN 
clock then synchronizes peripheral oscillators via neuronal connection and/or chemical 
signals. Thus, while circadian gene expression persists in peripheral organs of SCN-lesioned 
mice, their phases are no longer coordinated, neither between the same organs in different 
individuals nor between different organs in the same individual [17]. These peripheral 
oscillators are probably responsible for the circadian control of animal physiology. Indeed, 
analysis of animal transcriptome with the DNA microarray technology shows that many 
genes involved in different aspects of physiology are directly controlled by the circadian 
clock [18,19]. However, mechanisms involved in these regulations are not yet well-known, 
but it is possible to think that transcription factors whose expression is controlled by the 
circadian clock may be involved [20]. In this way, the organism can create different “waves” 
of circadian gene expression by a transcription factor cascade, influencing in this way many 
physiological processes including drug metabolism. 
 
2. Control of drug metabolism by the circadian clock 
Until the first description of the incidence of the time of administration and the sleeping time 
induced by a barbiturate, it has been shown that the toxicity and the efficiency of many drugs 
changes during a 24-hours cycle (for a review see [21,22]). However, the molecular 
mechanisms involved in these processes have been demonstrated only recently. Indeed, 
Gorbacheva et al. have shown that in the mouse with a null allele of Bmal1 or a mutation of 
the Clock gene displayed increased sensibility to the toxic effect of the anticancer agent 
cyclophosphamide, whereas mice devoid of the two Cry genes were more resistant to this 
effect [23]. This result suggests that the circadian clock, by regulating genes involved in drug 
metabolism, directly or through circadian clock-regulated transcription factors, is directly 
involved in this time-dependent drug toxicity. Many efforts have thus been made to 
characterize the mechanisms involved in the transcriptional regulation of these genes by the 
circadian clock. 
2.1. The mammalian drug metabolism system 
The xenobiotic metabolism system consists of three groups of proteins assuming distinct and 
successive functions [24]. The phase I group is involved in the functionalization (inhibition 
or activation) of the drugs. It contains the microsomal P450 cytochrome super-family 
enzymes with oxidase, reductase or hydroxylase activities. The phase II group, or conjugating 
enzymes, comprises mainly sulfotransferases (SULT), UDP-glucuronotransferases (UGT), 
NAD(P)H:quinine oxidoreductases (NQO), epoxide hydrolases (EPH), glutathione S-
transferases (GSH), and N-acetyltransferases (NAT). Conjugation helps to make lipophilic 
compounds hydrophilic enough to subsequently facilitate their excretion into bile, faeces 
and/or urine by the transporters or phase III group, mainly ABC transporters like multidrug 
resistance-associated proteins (MRP) or P-glycoprotein (P-gp). These latter proteins facilitate 
the transport of xenobiotics outside the cell. In addition, some other proteins like 
Aminolevulinic acid synthase (ALAS1) and P450 oxidoreductase (POR) regulate the activity 
of most of the phase I enzymes. ALAS1 is the rate-limiting enzyme in heme synthesis, the 
prosthetic group of all cytochrome P450 enzymes. Since monooxygenase reaction realized by 
cytochromes P450 requires electrons that are extracted from NAD(P)H and transferred via 
the flavin group of POR to the heme group, the expression of cytochrome P450 enzymes, 
ALAS1 and POR have to be coordinated. 
Transcriptional regulation of these genes is complex in that their expression can be cell-type 
specific, daytime dependent and inducible by xenobiotic. Their induction involves several 
transcription factors considered to be xenobiotic receptors. The most important of them are 
the nuclear receptors CAR (constitutive androstane receptor) and PXR (pregnane X receptor), 
and the dioxin receptor (also called aryl hydrocarbon receptor, AhR), a PAS-domain helix-
loop-helix transcription factor (for a review, see[25]). These receptors are mainly expressed 
in the liver and the small intestine where they are sequestered in the cytoplasm and are 
associated with chaperones proteins. However in response to xenobiotic binding or activation 
signals activated by xenobiotics, they accumulate in the nucleus where they activate 
transcription of phase I, II and III genes, with some overlapping between the receptors (see 
Figure 2). 
2.2. Regulation by the circadian clock 
Transcriptome analysis of mouse liver revealed that approximately 10 % of rhythmically 
expressed genes include genes coding for enzymes involved in the three phases of xenobiotic 
detoxification [18,19,26]. Recent evidence suggests that it is also the case in the small 
intestine where the Cyp2b10 gene is one of the most rhythmically expressed genes (Fréderic 
Gachon, Gwendal LeMartelot and Ueli Schibler, unpublished results). If a direct regulation of 
these genes by BMAL1 could not be excluded, all the published evidence tends to rather 
involve a regulation by circadian clock-controlled transcription factors. Among them, the 
PARbZip (Proline and Acidic amino acid Rich basic-leucine zipper) transcription factors 
seem to play a pivotal role. This family of transcription factors is composed of three 
members: DBP (albumin site D-Binding Protein), TEF (Thyrotroph Embryonic Factor) and 
HLF (Hepatocyte Leukemia Factor). These proteins bind DNA elements of the consensus 
sequence 5’-VTTAYGTAAY-3’ (where V is C, G or A, and Y is C or T) as homo- or 
heterodimer. They are expressed under a robust circadian fashion in most organs, because of 
their direct regulation by the core circadian oscillator (for a review, see [27]). Mice devoid of 
these three genes present an important mortality since less than 20% of them are still alive 
after one year [28]. Transcriptome profiling revealed that PARbZip deficient mice exhibit a 
general downregulation of genes coding for enzymes involved in xenobiotic detoxification in 
liver and kidney [29]. These include genes encoding phase I (Cyp2b, Cyp2c, Cyp2a and 
Cyp3a), phase II (Ces3, Cml3,4,5, GST , and GST 3) and phase III (Abcg2) group of 
detoxification enzymes. In addition, the expression of the two enzymes required for the 
activity of cytochrome P450 enzymes ALAS1 and POR are also decreased. Recent evidence 
suggests that these PARbZip proteins regulate directly the expression of some of these 
enzymes through rhythmic binding to their promoter regions. It is for example the case of 
Cyp3a4 [30] and Mdr1a (MultiDrug Resistance 1a or Abcb1a) genes [31]. However, it seems 
that the PARbZip transcription factors exert their action on xenobiotic metabolism mainly 
through the regulation of CAR [29]. Indeed, rhythmic CAR expression is strongly decreased 
in the liver and small intestine of PARbZip deficient mice. As a consequence, the strong 
daytime-dependent induction of Cyp2b10 mRNA by phenobarbital in liver (2.5-fold more 
important induction in the beginning of the night compare to the beginning of the day)and 
small intestine (6-fold difference between the day and night induction) of wild-type mice is 
severely compromised in PARbZip-deficient mice which have a very low induction 
throughout the day. Moreover, PARbZip-deficient mice are highly susceptible to toxicity 
induced by anticancer drugs such as cyclophosphamide and mitoxantrone. Interestingly, the 
time-dependent toxicity of pesticide in Drosophila [32] seems to involve a similar mechanism 
through the regulation of the CAR ortholog DHR96 by the PARbZip ortholog PDP1 [33]. 
PARbZip transcription factors are probably not the only circadian clock genes involved in 
drug detoxification. Indeed, ROR  and ROR  deficient mice present a perturbed expression 
of many phase I and phase II enzymes in addition to the expression of the xenobiotic receptor 
CAR [34]. Pxr [26] and AhR, in addition to its heterodimerization partner Arnt and its main 
target Cyp1a1, [35,36] are also expressed according to rhythmic pattern with a 2.5-fold 
amplitude, contributing in this way to the rhythmic induction of detoxifying enzymes. If no 
mechanisms have been characterized for Pxr, it seems that Per1 and Per2 genes play a role in 
the time-dependent induction of Cyp1a1 by the Ahr ligand 2,3,7,8-Tetrachlorodibenzo-p-
dioxin (TCDD) [37-39]. 
Interestingly, the expression of these three xenobiotic receptors reaches its nadir at the day-
night transition, just before the beginning of the active period of the animals. Since it the 
same for they target genes, the enzymes involved in xenobiotic metabolism are thus more 
expressed when the risk of exposure of these animals to xenobiotic is increased. As for many 
physiological events, the circadian clock allows their possessors to adapt their physiological 
needs to the time of day in an anticipatory way. 
2.3. Role of circadian clock-regulated post-transcriptional regulation 
Most of the enzymes involved in liver metabolism, mainly cytochrome P450, are localized in 
the membrane of the endoplasmic reticulum (ER) of the cells. The ER is a complex luminal 
network in which protein synthesis, maturation, folding, and transport take place. ER of 
hepatocytes exhibits a circadian dilatation in rat liver, a sign of activation of ER stress [40]. 
This ER stress triggers the Integrated Stress Response (ISR) which is a conserved adaptative 
response to cope with the accumulation of unfolded proteins in this organelle. When unfolded 
proteins accumulate in ER, three pathways are activated, IRE1 , PERK and ATF6, which 
lead to the nuclear translocation of the transcription factors XBP1, ATF4 and ATF6, 
respectively. These transcription factors activate in turn the expression of genes coding for 
proteins involved in peptide folding and degradation to limit the accumulation of unfolded 
proteins [41]. In this context, we have recently described the post-translational regulation of 
liver enzymes through a circadian clock-coordinated rhythmic activation of the IRE1  
pathway which exhibits a 12 hour period [42]. It has been described in yeast [43] and in 
mammalian cultured cells [44,45] that induction of cytochrome P450 enzymes by itself is 
sufficient to induce ISR. Previous reports have shown that induction of cytochrome P450 
enzymes after injection of phenobarbital induces ER hypertrophy, a sign of ER stress [46]. 
Interestingly, it has been shown in yeast that activation of IRE1 is required for proper 
expression and activity of cytochrome P450 enzymes [47]. In addition, activation of the ISR 
has often been linked to the resistance of tumor cells to chemotherapeutics agents [48-51]. 
We have described that Cry1/Cry2 knockout mice, which are devoid of a functional circadian 
clock, present a constitutive activation of IRE1  [42]. Considering the fact that these mice 
present a high resistance to xenobiotics throughout a 24 hour period [23], the statement that 
the ISR could be involved in this process constitutes an attractive hypothesis. 
Other circadian clock-coordinated events could influence liver detoxification. For example, 
the ultradian secretion patterns of Growth Hormone (GH) are directly responsible for the 
sexually dimorphic expression of several hepatic enzymes involved in drug metabolism, 
mainly cytochrome P450 [52]. Interestingly, this dimorphism is impaired in Cry1/Cry2 
knockout mice, with males exhibiting a feminized pattern of expression of liver enzymes 
likely because of altered ultradian GH secretion in absence of a functional circadian clock 
[53], contributing in this way to the drug metabolizing capacity of these animals. 
 
3. Role of circadian timing system in drug elimination 
3.1. Elimination by the hepatobiliary system 
If some metabolized drugs are preferentially excreted into plasma and subsequently urine, an 
important part of them are excreted through the hepatobiliary system. This transport system is 
essential for bile formation and hepatic elimination of various endo- and xenobiotics 
including bile salts, cholesterol, phospholipids, and drugs (For a review, see [54]). These 
biliary compounds secreted into bile are finally transported into the intestine and eliminated 
by the feces. The liver comprises a broad range of specific export systems for various biliary 
compounds. Bile is primarily formed by canalicular excretion of bile salts and non-bile salt 
organic anions via ATP-binding cassette (ABC) transporters. Monovalent bile salts (BS) are 
excreted via the canalicular bile salt export pump (Bsep or Abcb11) while divalent BS 
together with anionic conjugates of xeno or endo-biotics are excreted via the canalicular 
conjugate export pump (Mrp2 or Abcc2). The phospholipid export pump (Mdr2 or Abcb4) 
facilitates excretion of phosphatidylcholine (PC), which forms mixed micelles in bile 
together with BS and cholesterol. Cationic metabolized drugs are excreted by the multidrug 
export pump (Mdr1 or Abcb1). Other canalicular export pumps include the two-half 
transporter Abcg5/g8 for cholesterol and the breast cancer resistance protein (Bcrp or Abcg2) 
for anionic conjugates (see Figure 3A). 
It has been known for a long time that biliary excretion of bile acids, lipids and xenobiotics 
into the bile follow a circadian rhythm, with a maximum of excretion during the night 
[55,56]. Many simultaneous mechanisms are involved in this phenomenon. First, bile acid 
synthesis follows a diurnal rhythm in both rodent [57] and human [58]. This synthesis 
involves the cholesterol-7α-hydroxylase (CYP7A1), the rate-limiting enzyme in converting 
cholesterol to bile acids, whose rhythmic expression is directly regulated by the circadian 
clock, mainly through the clock-regulated transcriptional repressor REV-ERB  [59-61]. In 
addition, according to the analysis of the transcriptome of mouse liver [62,63], all the genes 
encoding the previously described transporters are expressed according to a circadian pattern, 
with for most of them a maximum of expression just before the active phase of the animals 
(see Figure 3B). As a consequence, it is not surprising to observe that the biliary excretion of 
drugs, for example flomoxef, presents a diurnal pattern in patients with percutaneous 
transhepatic biliary drainage [64]. 
It has also been shown that bile acids bind to and activate PXR, facilitating in this way the 
elimination of toxic forms of these cholesterol derivatives [65,66]. In addition, the Farnesoid 
X Receptor (FXR), a nuclear receptor which binds specifically bile acids, is able to activate 
the expression of Pxr [67]. As a consequence, conditions which lead to the accumulation of 
bile acids in the liver stimulate the expression of PXR target genes, increasing in this manner 
its detoxification capacity [68-70]. The rhythmic accumulation of bile acids in the liver can 
thus contribute to the rhythmic detoxification process through the establishment of a daily 
basal activation of detoxifying enzymes [29,61]. 
Finally, metabolized drugs contained in bile are eliminated by the feces after their excretion 
in the intestine. Interestingly, the contractile motility of all the gastrointestinal system follows 
a circadian rhythm with a maximum of contractibility during the night, contributing in this 
way to the rhythmic excretion of drugs (for a review, see [71]). At least for the colon, this 
rhythmic motility seems to be regulated by the circadian clock as this colonic motility is 
severely perturbed in mice with a deletion of the Per1 and Per2 genes which are devoid of a 
functional molecular clock [72]. 
3.2. Elimination by the kidney 
The great majority of water-soluble drugs or drug metabolites are eliminated by the kidney. 
Impairment of renal function with age or disease can significantly slow down this process 
thereby prolonging the half-life of drugs in the body. The rate of drug elimination in the urine 
depends on several intrinsic renal variables including the renal blood flow (RBF), the 
glomerular filtration rate (GFR), the capacity of the kidney to reabsorb or to secrete drug 
molecules across the tubular epithelium, the urine flow and the degree of urine 
alkalinization/acidification by the kidney (urine pH). All these functional variables have been 
shown to follow circadian rhythms. The kidney is also increasingly recognized as an 
important place of drug metabolism. Recent studies have shown that expression of many drug 
metabolizing enzymes in the kidney exhibit robust circadian patterns. Below, we discuss the 
potential role of molecular clock in the regulation of several key parameters determining 
renal drug disposal. 
3.2.1. Renal Blood Flow 
The kidney is a highly perfused organ receiving approximately 20% of cardiac output. About 
1/5 of the RBF is converted into primary urine through glomerular filtration. Many ionized 
drugs can also be secreted in the urine from the remaining 4/5 of unfiltered blood via various 
active transport systems located mainly in the proximal tubule (see below). Finally, filtered 
and secreted drugs may be passively or actively reabsorbed out of the urine into the blood. 
Because, the RBF largely determines both the glomerualr filtration and secretion, this 
parameter is closely correlated to the clearance of many ionized drugs in the urine. The RBF 
exhibit a significant circadian rhythm with a peak during the activity phase and a trough 
during the rest, with an amplitude of approximately 50 % [73,74]. This rhythm is at least 
partially entrained by the circadian rhythms in the arterial blood pressure and the cardiac 
output. Furthermore, there is a growing body of evidence that the RBF rhythm could be 
generated by the intrinsic renal mechanisms responsible for maintaining appropriate levels of 
the RBF (RBF autoregulation). For instance, circadian clock deficient Cry1/Cry2-null mice 
exhibit significantly modified activity of the renin-angiotensin-aldosterone system, one of the 
major mechanisms regulating renal hemodynamics [75]. 
3.2.2. Glomerular Filtration Rate 
Circadian oscillations in the GFR are apparently synchronized with those of the RBF and 
systemic hemodynamics, with an approximately 50 % increase at the day-night transition. 
However, they are not fully determined by these factors. For instance, the GFR rhythm 
persists during continuous bed rest and in the condition of inverted blood pressure rhythm 
[73,76]. The GFR rhythm is also maintained in patients with transplanted kidneys, indicating 
that sympathetic innervation is not required for the persistence of this rhythm [77]. 
Collectively, these data indicate that an intrinsic renal mechanism entrains circadian 
rhythmicity in the GFR. However, the exact structural element(s) of glomerular filtration 
barrier responsible for this functional rhythmicity remains unknown. 
3.2.3. Reabsorption and secretion of drugs in the renal tubule 
Both reabsorption and secretion of water-soluble drugs in the kidney critically depends on the 
expression of membrane transporters that facilitate diffusion of polar molecules through the 
apical and/or basolateral membranes of tubular cells. Most of these transporters belong to two 
superfamilies of proteins, namely the ABC transporters and the solute carriers (Slc). Studies 
performed in the liver and intestine have shown that expression of many genes encoding the 
ABC and Slc transporters is directly or indirectly controlled by the circadian clock. In the 
kidney, the bulk of drug reabsorption/secretion takes place in the proximal tubule. This part 
of the renal tubule is enriched by various transporter systems which exhibit a preferential 
affinity to the small-size (molecular weight < 500 Da) organic anions [78]. Transporters with 
proven role in renal drug disposal include the OAT1, OAT3, OAT4, OATP4C1, OCT2, 
OCTN1/2 and MATE1/2 Slc transporters and, MDR1, MRP2, MRP4, MRP6 and BCRP 
ABC transporters. Circadian expression profiles of proximal transporter systems remain 
poorly characterized. However, Zuber et al. have recently shown that several of the above-
mentioned transporters exhibit robust circadian expression pattern in the more distal nephron 
segments, namely in the distal nephron and the collecting duct [79]. For instance, the OAT1 
and OAT3, two transporters that mediate the basolateral secretion of a wide variety of drugs 
exhibit clear circadian expression patterns, with a maximum of expression during the night 
(see Figure 4). Expression of MRP4 (Abcc4) and OAT2 are significantly reduced in the 
kidney of PARbZip knockout mice, thereby providing direct evidence for the control of 
tubular reabsorption/secretion by the circadian clock [29]. 
3.2.4. Effect of circadian clock on urine pH 
Urine pH is the major factor which determines the degree of drug ionization. The drug 
ionization, in turn, determines the drug lipid solubility and, finally, the rate of drug 
reabsorption in the nephron. The human urine pH may range from 4.5 to 8 and it usually 
exhibits lower values in the morning. The urine pH is maintained by a complex system which 
combines rebasorption/secretion/production of bicarbonate and secretion of protons. The 
different elements of this system are distributed all along the nephron. The most important 
transporter which is involved in protons secretion in the kidney is the sodium-proton 
exchanger 3 (NHE3 or Slc9A3) expressed in the proximal tubule and Henle’s loop. Rohman 
wt al. have shown that expression of NHE3 mRNA and protein in the kidney exhibit robust 
circadian rhythm with the maximal expression which takes place in the middle of the activity 
phase [80]. This circadian expression pattern was significantly blunted in cry1/cry2 knockout 
mice. Analysis of promoter region of the NHE3 gene allowed identification of 
CLOCK/BMAL1 binding site (E box) in the vicinity of its transcription initiation site and the 
electrophoretic mobility shift assay confirmed the direct interaction of CLOCK/BMALI 
heterodimers with the NHE3 promoter. Collectively, these data indicate that circadian clock 
can influence the renal drug disposal via the control of urine acidification. 
3.2.5. Renal drug metabolism 
The kidney is the organ which exhibits a highest extrahepatic activity of drug-metabolizing 
enzymes. Moreover, most of hepatic phase I and phase II enzymes are abundantly 
represented in different parts of the renal tubule. Recent studies have shown that renal drug 
metabolism is regulated by the circadian clock in a similar way as that in the liver. Indeed, it 
was shown that renal expression of a great number of phase I and phase II enzymes is 
significantly reduced in mice devoid of PARbZip transcription factors [29]. Zuber et al. have 
recently shown that circadian variations in expression of drug metabolizing enzymes also 
takes place in the distal nephron and the collecting duct, the parts of the renal tubule which 
are usually not considered important sites of xenobiotics metabolism [79]. A possible 
explanation for this observation consists in the fact that extensive water reabsorption in the 
kidney results in a dramatic increase in the intratubular concentration of polar xenobiotics in 
the distal parts of the renal tubule. Thus, the biological meaning for expression of drug-
metabolizing enzymes in the distal nephron and the collecting duct and their regulation by the 
circadian clock could be the requirements for protection of distal tubular epithelium form the 
high xenobiotics concentration. 
 
4. Expert Opinion 
It is known for a long time that drug absorption and distribution present diurnal variations, 
resulting probably from diurnal changes in various aspects of physiology (for a review, see 
[22]). However, in recent years, significant progress has been achieved in understanding the 
molecular mechanisms governing circadian rhythms of drug detoxification. These findings 
have boosted expectations for chronopharmacology, a domain of general pharmacology 
aiming at the improvement of drug efficacity and safety via the coordination of time of 
medication with biological rhythms. However, in which way might these new resources be 
useful to practical pharmacology? Obviously, one of the most interesting applications is to 
tailor the time of drug treatment with circadian changes in activity/expression of drug 
metabolizing enzymes and drug transporters. Indeed, new tools of RNA expression analysis 
(microarrays, high throughput sequencing, SAGE), have provided a comprehensive analysis 
of circadian transcriptomes for the principal tissues in which drug absorption, distribution, 
metabolism and elimination take place (liver, intestine, kidney, lung, etc.). Accordingly, the 
tissue-specific circadian expression patterns of mRNAs encoding drug metabolizing enzymes 
and drug transporters are now well characterized. A priori, these data may be used for 
prediction or interpretation of circadian variations in drug pharmacokinetics (domain of 
chronopharmacokinetics). However, several important issues remain to be addressed. First, 
the rhythmic expression of mRNA does not necessarily result in circadian oscillations of 
protein abundance. Indeed, proteins with long half-lives (e.g. 24 hours) would exhibit only 
low circadian amplitudes of abundance despite high circadian variations in corresponding 
RNA. Inversely, Reddy et al., have shown that about a half of cycling proteins are encoded 
by transcripts which do not exhibit circadian oscillations [81]. Also, the protein abundance is 
not necessarily correlating with its function, due to a multitude of potential post-translational 
modifications. Thus, significant progress in the characterization of circadian variations in 
protein expression and activity is clearly required. Second, most of the circadian expression 
data are available only for rat or mouse. However, numerous studies have shown that the 
expression and/or functional properties of drug metabolizing enzymes and drug transporters 
are highly species-specific [82]. This raises concerns of the relevance of circadian profiling 
data obtained in animal models to the human chronopharmacokinetics. Third, little is yet 
known about the interaction of the circadian timing system with sex, age, pathology and 
environmental stress. All these factors are able to dampen or abolish circadian rhythms 
and/or to produce their permanent or temporary phase shift. As a consequence, the efficiency 
of the chronopharmacological treatments of cancers appears to be strongly dependent on the 
sex and the activity profile of the patients [83]. Finally, the interaction between circadian 
clocks involved in the different steps of drug detoxification remains only poorly 
characterized. Obviously, the development of modern chronopharmacology will depend on 
the progress in solving these questions. 
Another aspect of the detoxification process has emerged from the study of longevity in 
different species. Indeed, it has been shown in the nematode Caenorhabditis elegans that 
signaling through the DAF-2/insulin growth factor receptor plays a particularly important 
role in determining the age of nematodes, and reduction of DAF-2 signaling increases life 
span up to 2-fold. Longevity is also extended in dauer larvae, a state induced by 
environmentally unfavorable conditions [84]. Interestingly, a DNA microarray search for 
transcripts whose accumulation is upregulated in both daf-2 mutant worms and dauer larvae 
revealed a specific enrichment for mRNAs encoding cytochrome P450 enzymes, 
oxidoreductases, carboxyl esterases, short-chain dehydrogenases/ reductases, UDP-
glucuronosyl/glucosyltransferases, sulfotransferases, and glutathione-S-transferases [85]. 
This observation is also true in rodents. Indeed, increased longevity induced by caloric 
restriction in mice correlates also with increased expression of genes involved in liver 
detoxification [86]. In addition, the liver of long lived Little [87] and Ames [88] mice present 
also an increased xenobiotic detoxification capacity [68,89]. Not surprisingly, it has been 
described that the detoxification capacity decreases with age in both rodents and humans 
[90], likely due to the decreased expression of detoxification enzymes [91,92]. In addition to 
the fact that this information is of great interest to the biology of ageing, it could also explain 
important changes in drug metabolism observed in the elderly, which could have a great 
impact on the efficiency and the side effects of pharmacological treatments [93-95]. 
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Legends to Figures 
 
Figure 1: The mammalian circadian oscillator. 
The molecular mammalian circadian clock is based on a molecular negative feedback loop. 
This loop is initiated by BMAL1 heterodimers which drive expression of their own negative 
regulators, the period (PER1 and PER2) and the cryptochromes (CRY1 and CRY2) proteins. 
Over the course of the day, the PER and CRY proteins form compexes in the cytoplasm, 
where they are phosphorylated by casein kinase I, which induces in this way their 
translocation into the nucleus where they interact with and inhibit the BMAL1 heterodimers 
to repress their own activator. At the end of the circadian cycle, the PER and CRY proteins 
are degraded in a CKI- and APMK-dependent manner, which releases the repression of the 
transcription and allows the next cycle to start. An additional stabilizing feedback loop 
involves the activator ROR and the inhibitor REV-ERB which control Bmal1 expression and 
reinforce the oscillations. 
 
Figure 2: Schematic model of xenobiotic receptor transcriptional regulation of 
detoxification. 
A. Xenobiotic receptors are linked in the cytoplasm by chaperones proteins. After direct 
ligand binding or indirect dissociation of the XR from its chaperones through activation by 
indirect activators, the XR enters the nucleus, dimerizes with its heterodimeric partner and 
activates transcription after binding to its specific responsive element. 
B. Distinct and overlapping target of XR. The left panel described the target genes shared by 
CAR and PXR, the right panel the genes regulated by AhR.. Specific PXR and CAR target 
genes are not indicated. It is interesting to note that Ugta1 is regulated by the three XR. 
 
Figure 3: Rhythmic elimination of xenobiotic by the hepatobiliary system. 
A. Schematic representation of the hepatobiliary system in the liver. The different 
transporters involved in the excretion of bile salts (BS), phospholipids (PC), cholesterol 
(Chol), and anionic (OA) and cationic (OC) conjugates of xenobiotics are indicated on the 
figure. 
B. Rhythmic expression of the transporters involved in bile excretion in the liver. The 
rhythmic mRNA expression of all the indicated transporters are plotted based on the 
microarray data published by Miller et al. [63]. 
 
Figure 4: Circadian expression pattern of OAT1 and OAT3 in the distal nephron. 
The time-point dependent arbitrary expression levels are calculated from the microarray data 
published by Zuber et al. [79]. 
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